Task: Answer the multiple choice question.
Query: Which drug exhibits a -6.073\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1nnc(N2CCOCC2)c2nn(-c3ccccc3)c(C)c12
b.) COc1ccc(C(=O)N/N=C(\C)c2cccc(NC(=O)c3ccc(F)cc3)c2)c(OC)c1
Answer: a. Cc1nnc(N2CCOCC2)c2nn(-c3ccccc3)c(C)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(N2CCOCC2)c2nn(-c3ccccc3)c(C)c12
Cc1nnc(N2CCOCC2)c2nn(-c3ccccc3)c(C)c12
4-(3,4-dimethyl-2-phenylpyrazolo[3,4-d]pyridazin-7-yl)morpholine